Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01067599 · ClinicalTrials.gov registry record · NA

Novel Determinants and Measures of Smokeless Tobacco Use: Study 2

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
278
Enrollment target

NCT01067599: Completed NA study, sponsored by University of Minnesota.

NCT01067599 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 278 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01067599, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
278 participants
Enrollment target

Study Summary

The research project will determine the level of nicotine in ST products that will lead to the greatest reduction in toxicant exposure

Interventions

  • OTHER Low nicotine
  • OTHER Medium nicotine
  • OTHER High nicotine

Trial Details

FieldValue
Enrollment Target 278 participants
Start Date 2012-03
Est. Completion 2016-10
Phase NA
University of Minnesota

966 total trials

What the finished NCT01067599 record still lists

NCT01067599 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 3 interventions - of which Low nicotine is the first listed.

NCT01067599 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01067599 about?

NCT01067599 is a clinical study titled "Novel Determinants and Measures of Smokeless Tobacco Use: Study 2". The research project will determine the level of nicotine in ST products that will lead to the greatest reduction in toxicant exposure

What is the current status of trial NCT01067599?

This trial is currently completed. It is a NA study. The enrollment target is 278 participants. The study started on 2012-03. Estimated completion is 2016-10.

What interventions are being tested in trial NCT01067599?

The interventions under investigation include: Low nicotine (OTHER), Medium nicotine (OTHER), High nicotine (OTHER).

Who is sponsoring clinical trial NCT01067599?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01067599's enrollment target sits among peer trials

278 382nd of 2000 higher than 1,618 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04586959 · 278 participants · NA

    Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

  • NCT05010148 · 278 participants · Phase 3

    A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain

  • NCT05489237 · 278 participants · Phase 1

    First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

  • NCT05965245 · 278 participants · NA

    Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01067599, the US trial registry maintained by the National Library of Medicine. NCT01067599 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.